MediPal Holdings Corporation (MAHLY)
OTCMKTS
· Delayed Price · Currency is USD
15.00
+0.75 (5.00%)
Apr 9, 2025, 4:00 PM EDT
MediPal Holdings Revenue
MediPal Holdings had revenue of 982.50B JPY in the quarter ending December 31, 2024, with 4.98% growth. This brings the company's revenue in the last twelve months to 3.65T, up 4.09% year-over-year. In the fiscal year ending March 31, 2024, MediPal Holdings had annual revenue of 3.56T with 5.91% growth.
Revenue (ttm)
3,650.99B JPY
Revenue Growth
+4.09%
P/S Ratio
n/a
Revenue / Employee
279.23M JPY
Employees
13,075
Market Cap
3.29B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 3,558.73B | 198.72B | 5.91% |
Mar 31, 2023 | 3,360.01B | 69.09B | 2.10% |
Mar 31, 2022 | 3,290.92B | 79.80B | 2.48% |
Mar 31, 2021 | 3,211.13B | -41.95B | -1.29% |
Mar 31, 2020 | 3,253.08B | 71.15B | 2.24% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 16.04M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
Northwest Biotherapeutics | 1.38M |
Global Cord Blood | 196.10M |
Longduoduo Company | 6.01M |